Navigation Links
Federal testing for mad cow disease a failure, law review editor says

The U.S. Agriculture Department's mad cow disease-testing program is wholly inadequate and the agency's refusal to let processors do their own testing further undercuts the safety of American beef, a University of Illinois scholar writes.

Eating meat from cattle infected with bovine spongiform encephalopathy, or mad cow disease, can cause Creutzfeldt-Jakob disease, a fatal human brain-wasting disorder. More than 160 deaths in Britain were attributed to eating BSE-infected beef, and the disease spread to Europe and Asia before the slaughter of cattle and better testing helped curb the outbreak.

The Bush administration's approach to safeguarding the nation's supply of beef has been to deny that there's a problem and to resist comprehensive BSE testing, Gregory L. Berlowitz, an editor at the University of Illinois Law Review, wrote. The net result is that the USDA has placed the welfare and promotional concerns of the beef industry ahead of public welfare.

The first case of BSE in the U.S. was reported in December 2003 at a farm in Washington state. Because the cow was of Canadian origin, USDA officials insisted that the American beef supply was safe. However, after Japan and 52 other countries banned U.S. beef, the USDA started a program to test half of the nation's 450,000 "downer" cows, or cows that could not walk.

The surveillance program found no cases of mad cow disease until June 24, 2005. "This cow was of American origin," Berlowitz wrote, "but even more disturbing, the cow had been tested for BSE in November 2004, and had been retested only on the recommendation of the Office of Inspector General," which is an independent watchdog group within the USDA.

The Bush administration, in the meantime, had restored about one-third of U.S. beef exports through intense lobbying, but Japan, the biggest export market, continued to resist. The administration argued that there was no risk to humans because the second cow had not been
'"/>

Source:University of Illinois at Urbana-Champaign


Page: 1 2 3 4

Related biology news :

1. Federal grant funds research on novel HIV therapy
2. Drug resistance testing in treatment-naive HIV patients is cost-effective
3. Researchers develop new testing methods for potential monkeypox or smallpox outbreak
4. Genetic testing still smart choice, despite uncertainties
5. Faster immune system testing set to improve poultry quality
6. Professors to develop hand-held pathogen testing device
7. New research to cut animal testing
8. UW launches study testing adult stem cells for heart damage repair
9. Neuronal traffic jam marks early Alzheimers disease
10. Scientists detect probable genetic cause of some Parkinsons disease cases
11. Ecological destruction fuels emerging diseases
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Federal testing for mad cow disease failure law review editor says

(Date:11/5/2014)... of biology in the UTSA College of Sciences, ... selected to receive a two-year $300,00 National Science ... (EAGER). The funding supports President Obama,s BRAIN Initiative, ... new technology that will demystify complex brain processes. ... neuroscience are broken into the interactions of multiple ...
(Date:11/5/2014)... de Janeiro, Brazil -Individuals show great diversity in their ... males and females greatly differ in their perceptual evaluation ... of smell tests. , Sex differences in ... behaviors and may be connected to one,s perception of ... emotions. Thus, women,s olfactory superiority has been suggested to ...
(Date:11/4/2014)... the right time might actually help boost a species, ... in understanding animal populations, pest control and managing fish ... journal Trends in Ecology and Evolution , a ... kind of positive population effect an overall species experiences ... the size and developmental stage of the creatures that ...
Breaking Biology News(10 mins):UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3The female nose always knows: Do women have more olfactory neurons? 2When less is more: Death in moderation boosts population density in nature 2
... of copying the body’s own natural "waste disposal" chemistry to ... percent of patients with urea cycle disorders --- most of ... New England Journal of Medicine summarizing a quarter century of ... phenylacetate and sodium benzoate, two chemicals the body already makes ...
... the government of The Gambia is encouraging citizens living ... to try an unproven herbal remedy. The HIV Medicine ... his unproven claims that the treatment "cures" AIDS. ... treatment to a handful of patients who had been ...
... isn’t such a good thing after all. , ... say they have confirmed what other scientists have only ... can help build stronger immune systems, and may protect ... that infants who were exposed to high levels of ...
Cached Biology News:An 'elegant' idea proves its worth 25 years later 2HIVMA opposes The Gambia's unproven AIDS remedy 2Early exposure to indoor fungus molecules may protect infants against future allergies 2
(Date:11/27/2014)... The Europe Thermal Protective Clothing market ... crucial revenue forecasts. It estimates the market to ... CAGR of 7.5%, from 2013 to 2018. , ... Protective Clothing market report for a glimpse of ... various tables and figures. , http://www.micromarketmonitor.com/market/europe-thermal-protective-clothing-5957050557.html ...
(Date:11/27/2014)... -- First articles published now available ... Elsevier , a world-leading provider of scientific, technical and ... the launch of a new journal: Extreme ... launch of Extreme Mechanics Letters is driven ... applied sciences such as micro and nanotechnologies, biotechnologies, soft ...
(Date:11/26/2014)... 2014 (PRWEB) November 26, 2014 Publicis ... network, today announced the organization has won a total ... Awards. Digitas Health LifeBrands was honored with a Silver ... PHCG agencies received eight Awards of Excellence. , ... of pharmaceutical advertising and promotion. The Awards provide a ...
(Date:11/26/2014)... November 26, 2014 The North ... segments the market for detailed analysis of the ... market to reach $616.3 million by 2018, growing ... 2018. , Browse through the TOC of the ... get an idea of the in-depth analysis and ...
Breaking Biology Technology:The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 2The Europe Thermal Protective Clothing market is estimated to grow up to $577.9 million by 2018 - Report by MicroMarket Monitor 3Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Publicis Healthcare Wins 20 Rx Club Awards 2Publicis Healthcare Wins 20 Rx Club Awards 3The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 2The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 3
... Loramyc(R) Completes Patient Enrollment Ahead ... Zensana(TM) Reformulation Complete, Resubmission on Target, WOODCLIFF ... (NYSE: PRX ) today provided an update ... pipeline,products: pafuramidine, Loramyc(R) (miconazole Lauriad(R)), and Zensana(TM),(ondansetron). These ...
... Schering-Plough,Corporation (NYSE: SGP ) will provide a ... Hassan, chairman and chief executive officer, followed,by a ... Conference on Jan. 3, 2008, at approximately 8:45 ... "unplugged" presentation., Included in Mr. Hassan,s comments ...
... Schering-Plough,Corporation (NYSE: SGP ) is scheduled to ... quarter and full year on Tuesday, Feb. 12,2008., ... conduct a conference,call to review results for the 2007 ... and CEO, and other members of management,will host the ...
Cached Biology Technology:Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 3Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 4Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 5Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result 2